We came across a bullish thesis on Teva Pharmaceutical Industries Limited (TEVA) on Substack by Kontra. In this article, we ...

Corteva develops its pipeline through the investment of around 8% of sales in research and development. New products should generate sales and profit growth even as patents expire and generic ...

For an accessible version of this Press Release, please visit On track for 30% operating profit margin by 2027 in line with ...

BioCryst Pharma's ORLADEYO leads HAE market growth, with strong financial performance and potential despite rising ...

What is required is a digital twin of the development process itself on which AI can operate. Semiconductor Engineering sat down with a panel of experts to discuss these issues and others, including ...

With its commitment to non-invasive, herbal support for prostate function and urinary flow, ProstAfense positions itself as a ...

Teva Pharmaceutical Industries Ltd (TEVA) reports robust revenue growth and strategic advancements, despite challenges in the ...

US President Donald Trump's new order poses a challenge to the Indian pharma sector. But there is one pharma company that may ...

Key Highlights Alps Alpine selects Jivaro Pro to improve designer productivity and safeguard time-to-market goalsJivaro Pro is a unique stand-alone tool offering advanced parasitic reduction to ...

Q1 2025 Earnings Call Transcript May 1, 2025 Operator: Good morning and welcome to the First Quarter 2025 Earnings Call for the FMC Corporation. This event is being recorded. All participants are in a ...

Q1 2025 Earnings Call Transcript May 6, 2025 PTC Therapeutics, Inc. beats earnings expectations. Reported EPS is $10.04, ...

Takeda (TOKYO:4502/NYSE:TAK) today announced financial results for fiscal year 2024 (period ended March 31, 2025) with continued strong momentum in Growth & ...